Incidence of Homozygous SMN2 Deletion in Japan: Cross-Reactivity of SMN2 Primers with SMN1 Sequence Causes False Negatives in Real-Time PCR Screening
Genes · 2025
DOI: 10.3390/genes16060712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Makoto Sakima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Nutrition, Kobe Gakuin University, 518 Arise, Ikawadani-cho, Nishi-ku, Kobe 651-2180, Japan. Hauptthemen laut MEDLINE: Survival of Motor Neuron 1 Protein, Survival of Motor Neuron 2 Protein, Muscular Atrophy, Spinal. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
SMN1 and SMN2 are causative and modifier genes, respectively, for spinal muscular atrophy (SMA). The incidence of SMN1 homozygous deletion in Japan is 1 in 20,000. However, the incidence of SMN2 homozygous deletion in Japan remains unknown.
Methods
To clarify the incidence of homozygous SMN2 deletion in Japan, real-time polymerase chain reaction (PCR) was performed on dried blood spot (DBS) samples collected from newborns nationwide. Samples with positive or ambiguous results were retested using PCR-restriction fragment length polymorphism (PCR-RFLP) and nucleotide sequence analysis.
Results
Of the 1000 DBS samples that were screened using real-time PCR, 51 were positive. Retesting using PCR-RFLP analysis identified 10 false results: six false positives and four false negatives. Therefore, there were 49 true positives among the 1000 samples. Notably, nucleotide sequence analysis revealed that the false negatives were caused by the cross-reactivity of SMN2 primers with SMN1 sequences.
Conclusions
The incidence of homozygous SMN2 deletion in Japan is approximately 1 in 20 people. This incidence is much higher than that of homozygous SMN1 deletion and may reflect the vulnerability of the SMN2 region. Importantly, the results of the present study suggest that false negatives in the screening process were caused by cross-reactivity with non-target gene sequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Nutrition, Kobe Gakuin University, 518 Arise, Ikawadani-cho, Nishi-ku, Kobe 651-2180, Japan.
- Department of Clinical Laboratory, Kobe University Hospital, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
- Department of Pediatrics, Graduate School of Medicine, Kobe University, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
- Organization for Research Initiative and Promotion, Research Initiative Center, Tottori University, 86 Nishi-cho, Yonago 683-8503, Japan.
- Department of Occupational Therapy, Faculty of Rehabilitation, Kobe Gakuin University, 518 Arise, Ikawadani-cho, Nishi-ku, Kobe 651-2180, Japan.
ORCID-Profile: Hiroyuki Awano, Hisahide Nishio
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Sakima, M., Bouike, Y., Wada, S. I., Nakamae, M., Noguchi, Y., Bo, R., Awano, H., Oba, J., & Nishio, H. (2025). Incidence of Homozygous SMN2 Deletion in Japan: Cross-Reactivity of SMN2 Primers with SMN1 Sequence Causes False Negatives in Real-Time PCR Screening. Genes. https://doi.org/10.3390/genes16060712
Vancouver
Sakima M, Bouike Y, Wada SI, Nakamae M, Noguchi Y, Bo R, et al. Incidence of Homozygous SMN2 Deletion in Japan: Cross-Reactivity of SMN2 Primers with SMN1 Sequence Causes False Negatives in Real-Time PCR Screening. Genes. 2025. doi:10.3390/genes16060712
BibTeX
@article{Sakima2025,
author = {Sakima, Makoto and Bouike, Yoshihiro and Wada, Shin-Ichi and Nakamae, Masami and Noguchi, Yoriko and Bo, Ryosuke and Awano, Hiroyuki and Oba, Jumpei and Nishio, Hisahide},
title = {Incidence of Homozygous SMN2 Deletion in Japan: Cross-Reactivity of SMN2 Primers with SMN1 Sequence Causes False Negatives in Real-Time PCR Screening},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16060712}
}
EUVIMED